- Investing Ideas
- /
- Belgian Large Cap High Growth Potential
Belgian Large Cap High Growth Potential
Results
4
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
4 companies
argenx
Market Cap: €44.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€718.60
7D
-2.3%
1Y
18.8%
Elia Group
Market Cap: €11.9b
Develops and operates as a transmission system operator in Belgium and Germany.
ELI
€108.70
7D
0.6%
1Y
46.6%
Groupe Bruxelles Lambert
Market Cap: €9.1b
Invests in a portfolio of industrial, consumer goods, and business service companies operating in various sectors in Belgium, other European countries, North America, and internationally.
GBLB
€75.30
7D
0.5%
1Y
15.7%
UCB
Market Cap: €44.7b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€235.50
7D
-2.4%
1Y
22.2%